Effect of metformin on outcomes of patients treated with immune checkpoint inhibitors: a retrospective cohort study

被引：0
|
作者：
Cho-Han Chiang
Yuan-Jen Chen
Cho-Hsien Chiang
Cheng-Ying Chen
Yu-Cheng Chang
Shih-Syuan Wang
Xin Ya See
Chuan-Sheng Horng
Chun-Yu Peng
Yuan Ping Hsia
Cheng-Ming Peng
Cho-Hung Chiang
机构：
[1] Mount Auburn Hospital,Department of Medicine
[2] Harvard Medical School,Department of Medicine
[3] Taipei Veterans General Hospital,Department of Medical Education
[4] Kuang Tien General Hospital,Department of Medical Education
[5] Cathay General Hospital,Da Vinci Minimally Invasive Surgery Center
[6] Chung Shan Medical University Hospital,Department of Medicine
[7] Unity Hospital,Department of Internal Medicine
[8] Rochester Regional Health,Department of Medicine
[9] Chung Shan Medical University Hospital,Department of Family Medicine, Taipei Tzu Chi Hospital
[10] Danbury Hospital,Department of Medicine, School of Medicine
[11] Buddhist Tzu Chi Medical Foundation,Department of Internal Medicine
[12] Chung Shan Medical University,Department of General Division, Taipei Tzu Chi Hospital
[13] National Taiwan University Hospital,undefined
[14] Buddhist Tzu Chi Medical Foundation,undefined
来源：
Cancer Immunology, Immunotherapy | 2023年 / 72卷
关键词：
Immune checkpoint inhibitors; Immunotherapy; Metformin; Drug re-purposing; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1951 / 1956
页数：5
相关论文
共 50 条
  • [1] Effect of metformin on outcomes of patients treated with immune checkpoint inhibitors: a retrospective cohort study
    Chiang, Cho-Han
    Chen, Yuan-Jen
    Chiang, Cho-Hsien
    Chen, Cheng-Ying
    Chang, Yu-Cheng
    Wang, Shih-Syuan
    See, Xin Ya
    Horng, Chuan-Sheng
    Peng, Chun-Yu
    Hsia, Yuan Ping
    Peng, Cheng-Ming
    Chiang, Cho-Hung
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (06) : 1951 - 1956
  • [2] The Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Outcomes of Patients Treated with Immune Checkpoint Inhibitors: a Retrospective Cohort Study
    Chiang, C. H.
    Wang, S. S.
    Chang, Y. C.
    Chiang, C. H.
    Chen, C. Y.
    Chen, Y. J.
    See, X. Y.
    Peng, C. Y.
    Hsia, Y. P.
    Chiang, C. H.
    Peng, C. M.
    CLINICAL ONCOLOGY, 2023, 35 (07) : 446 - 453
  • [3] The timing of statin initiation on survival outcomes of cancer patients treated with immune checkpoint inhibitors: A retrospective cohort study
    See, Xin Ya
    Chiang, Cho Hsien
    Chiang, Cho Han
    Chen, Yuan-Jen
    Chang, Yu-Cheng
    Wang, Shih-Syuan
    Peng, Chun-Yu
    Horng, Chuan-Sheng
    Hsia, Yuanping
    Chiang, Cho Hung
    Peng, Cheng-Ming
    Shiah, Her-Shyong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Atherosclerotic Cardiovascular Events in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Retrospective Cohort Study
    Tan, Sean
    Spear, Ella
    Sane, Nikhita
    Chan, Jasmine
    Nelson, Adam J.
    Alamgeer, Muhammad
    Nerlekar, Nitesh
    Segelov, Eva
    Nicholls, Stephen J.
    HEART LUNG AND CIRCULATION, 2024, 33 (05): : 721 - 729
  • [5] Palliative care consultation and end-of-life outcomes in a retrospective cohort of patients treated with immune checkpoint inhibitors
    Bloomer, Chance H.
    Faucheux, Andrew T.
    Quattlebaum, Alexander M.
    Elko, Catherine A.
    Hunting, John
    Khoury, Lara M.
    Olson, Eric
    Omlor, Rebecca
    Lycan, Thomas William
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Features of myositis and myasthenia gravis in patients treated with immune checkpoint inhibitors: a multicentric, retrospective cohort study
    Plomp, Lotta
    Chassepot, Hortense
    Psimaras, Dimitri
    Maisonobe, Thierry
    Mensi, Eric
    Leonard-Louis, Sarah
    Plu, Isabelle
    Rozes, Antoine
    Tubach, Florence
    Touat, Mehdi
    Anquetil, Celine
    Wesner, Nadege
    Champtiaux, Nicolas
    Rigolet, Aude
    Demeret, Sophie
    Weiss, Nicolas
    Alyanakian, Marie-Alexandra
    Le Panse, Rozen
    Truffault, Frederique
    Dragon-Durey, Marie-Agnes
    Chatenoud, Lucienne
    Abbar, Baptiste
    Bretagne, Marie-Claire
    Procureur, Adrien
    Similowski, Thomas
    Morelot-Panzini, Capucine
    Dres, Martin
    Ederhy, Stephane
    Benveniste, Olivier
    Salem, Joe-Elie
    Allenbach, Yves
    LANCET REGIONAL HEALTH-EUROPE, 2025, 50
  • [7] Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort Study
    Samy Babai
    Anne-Laure Voisin
    Célia Bertin
    Amandine Gouverneur
    Hervé Le-Louet
    Drug Safety, 2020, 43 : 111 - 117
  • [8] Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort Study
    Babai, Samy
    Voisin, Anne-Laure
    Bertin, Celia
    Gouverneur, Amandine
    Le-Louet, Herve
    DRUG SAFETY, 2020, 43 (02) : 111 - 117
  • [9] The Inpatient Immunotherapy Outcomes study: A multicenter retrospective study of patients treated with immune checkpoint inhibitors in the inpatient setting
    Riaz, Fauzia
    Zhu, Huili
    Cheng, Wei
    Brongiel, Samantha
    Baldwin, Elena
    Kier, Melanie Wain
    Zaemes, Jacob
    Hearn, Caleb
    Abdelghany, Osama
    Parikh, Ravi Bharat
    Reuss, Joshua E.
    Prsic, Elizabeth Horn
    Doroshow, Deborah Blythe
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 300 - 300
  • [10] Cardiotoxicity of immune checkpoint inhibitors: A retrospective cohort study of 93,362 patients
    Barzkar, Hasti
    Miles, Brittany
    Mehta, Ankit
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345